Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Heart Fail Clin. 2022 Jun 1;18(3):425–442. doi: 10.1016/j.hfc.2022.02.003

Fig. 1.

Fig. 1.

Consequences and mechanisms of direct and indirect tyrosine kinase inhibitor (TKI)-induced cardiotoxicity. ER, endoplasmic reticulum; IHD, ischemic heart disease; LV/RV, left ventricle/right ventricle; LVSD, left ventricular systolic dysfunction; ROS, reactive oxygen species; SVT, supraventricular tachycardia. (Created with BioRender.com.)